血小板衍生生长因子及其受体与肿瘤细胞的辐射抗性

杨学琴 刘芬菊

引用本文:
Citation:

血小板衍生生长因子及其受体与肿瘤细胞的辐射抗性

    通讯作者: 刘芬菊, fangsh@suda.edu.cn
  • 基金项目:

    国家自然科学基金资助项目(30870585)

Platelet derived growth factor and its receptor and the radiation resistance of tumor cells

    Corresponding author: LIU Fenju, fangsh@suda.edu.cn
  • 摘要: 在多种恶性肿瘤中,存在血小板衍生生长因子(PDGF)及其受体(PDGFR)自分泌生长刺激的异常合成。PDGF是有效的有丝分裂原和化学驱动剂,PDGFR属于酪氨酸激酶受体,当PDGFR与PDGF结合后,活化-系列下游信号通路,并产生众多的生物学效应。研究表明,PDGF和PDGFR的信号通路与肿瘤细胞辐射抗性密切相关,其机制可能与促进细胞增殖、抑制凋亡、调控细胞周期阻滞有关。
  • [1] Gridley DS, Williams JR, Slater JM. Low dose-low/dose rate radiation:a feasible strategy to improve cancer radiotherapy?[J], Cancer Therapy, 2005,3:105-130.
    [2] Yonezawa M. Induction of radio-resistance by low-dose X-irradiation[J], Yakugaku Zasshi, 2006, 126(10): 833-840.
    [3] Sakai K. Biological responses to low dose radiation hormesis and adaptive responses[J]. Yakugaku Zasshi, 2006,126(10): 827-831.
    [4] Hashiraoto S, Shirato H, Hosokawa M, et al. The suppression of metastase and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats[J]. Radiat Rest 1999, 151(6): 717-724.
    [5] Ito M, Shibamoto Y, Ayakawa S, et al. Effect of low-dose total-body irradiation on transplantability of tumor cells in syngeneic mice[J]. J Radiat Res (Tokyo), 2008t 49(2): 197-201.
    [6] Safwat A, Bayoumi Y, Akkooush H, et al. A phase Ⅱ trail of adjuvant low dose total body irradiation in non-Hodgkins lymphoma patients following standard CH0P[J]. Acta Oncol, 2004, 43(5): 480-485.
    [7] Thomas C, Fertil B, Foray N.Very low-dose hyper-radiosensitivity: impact for radiotherapy of raicroraetastases[J], Cancer Radiother, 2007,11(5): 260-265.
    [8] Safwat A, Bayoumi Y, El-Sharlcawy N, et al. The potential palliative role and possible immune modulatory effects of low-dose total bodyirradiation in relapsed or chemo-resistant non-Hodgkin's lymphoma[J], Radiother Oncol, 2003,69(1):33-36.
    [9] Safwat A, Schmidt H, Bastholt L, et al. A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma[J]. Radiother Oncol, 2005, 77(2): 143-147.
    [10] 贾廷珍,刘长安,杨光,等.脐血基础与临床研究[J].中华放射医学与防护杂志,2006,26(1):10-14.
    [11] 李秀娟,杨英,李修义,等.低剂量辐射抑制辐射诱发小鼠胸腺淋巴瘤免疫学机制[J].辐射研究与辐射工艺学报,1999,17(2): 125-127.
    [12] Zhou PK, Rigaud 0. Down-regulation of the human CDC16 gene after exposure to ionizing radiation: a possible role in the radioadaptive response[J]. Radiat Res, 2001,155(1 Pt l): 43-49.
    [13] 刘树铮.辐射免疫学研究的冋顾和展望[J].中华放射医学与防护杂志,2005,25(2): 193-200.
    [14] Hosoi Y. Antitumor effects by low dose total body irradiation[J], Yakugaku Zasshi, 2006,126(10): 841-848.
    [15] Chen Z, Sakai K. Enhancement of radiation-induced apoptosis by preirradiation with low-dose X-rays in human leukemia MOLT-4 cells[J]. J Radiat Res (Tokyo), 2004,45(2): 239-243.
    [16] Yu HS, Xue HW, Guo CB, et al. Low dose radiation increased the therapeutic efficacy of cyclophosphamide on S(I80) sarcoma bearing micefj], J Radiat Hes (Tokyo), 2007,48(4): 281-288.
    [17] Enns L, Bogen KT, Wizniak J, et al. Low dose radiation hypersensitivity is associated with p53-dependent apoptosis[J], Mol Cancer Res, 2004,2(10): 557-566.
    [18] Krueger SA, Collis SJ, Joiner MC, et al. Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity[J]. Int J Radiat Oncol Biol Phys, 2007,69(4): 1262-1271.
    [19] Bravard A, Luccioni C, Moustacchi E, et al. Contribution of antioxidant enzymes to the adaptive response to ionizing radiation of human lymphoblasts[J], Int J Radiat Biol, 1999,75(5): 639-645.
    [20] Pathak CM, Avti PK, Kumar S, et al. Whole body exposure to low-dose gamma radiation promotes kidney antioxidant status in Balb/c mice[J]. J Radiat Res (Tokyo), 2007,48(2): 113-120.
    [21] Sonveaux P, Dessy C, Brouet A, et al. Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery[J]. FASEB J, 2002, 16(14): 1979-1981.
  • [1] 刘永哲金顺子 . 白细胞介素24的研究进展. 国际放射医学核医学杂志, 2007, 31(3): 179-182.
    [2] 朱光旭王小华 . 肿瘤辐射敏感性与细胞凋亡. 国际放射医学核医学杂志, 2000, 24(2): 78-82.
    [3] 王丽平梁克 . 细胞凋亡与辐射敏感性. 国际放射医学核医学杂志, 2000, 24(2): 75-78.
    [4] 刘光伟龚守良 . 细胞凋亡的线粒体调控机制与电离辐射. 国际放射医学核医学杂志, 2003, 27(2): 90-93.
    [5] 李雨民孙元明夏寿莹 . 辐射与细胞凋亡及其基因调控. 国际放射医学核医学杂志, 1995, 19(3): 125-128.
    [6] 苑宾王宝勤李雨民鞠桂芝 . 辐射诱导细胞凋亡的基因调控. 国际放射医学核医学杂志, 1998, 22(6): 269-273.
    [7] 吴玮孔宪涛杨如俊 . Fas系统与辐射所致细胞凋亡. 国际放射医学核医学杂志, 1998, 22(4): 177-180.
    [8] 何子毅孟庆勇 . 电离辐射与细胞凋亡. 国际放射医学核医学杂志, 2004, 28(2): 90-93.
    [9] 李峰生陈肖华 . RNA干涉治疗脑胶质瘤的研究进展. 国际放射医学核医学杂志, 2007, 31(5): 300-302.
    [10] 张海兵章龙珍 . 低剂量照射在肿瘤治疗中的应用研究进展. 国际放射医学核医学杂志, 2008, 32(4): 243-246.
  • 加载中
计量
  • 文章访问数:  1376
  • HTML全文浏览量:  80
  • PDF下载量:  2
出版历程
  • 收稿日期:  2007-11-14

血小板衍生生长因子及其受体与肿瘤细胞的辐射抗性

    通讯作者: 刘芬菊, fangsh@suda.edu.cn
  • 215123 苏州, 苏州大学医学部放射医学与公共卫生学院放射生物学教研室
基金项目:  国家自然科学基金资助项目(30870585)

摘要: 在多种恶性肿瘤中,存在血小板衍生生长因子(PDGF)及其受体(PDGFR)自分泌生长刺激的异常合成。PDGF是有效的有丝分裂原和化学驱动剂,PDGFR属于酪氨酸激酶受体,当PDGFR与PDGF结合后,活化-系列下游信号通路,并产生众多的生物学效应。研究表明,PDGF和PDGFR的信号通路与肿瘤细胞辐射抗性密切相关,其机制可能与促进细胞增殖、抑制凋亡、调控细胞周期阻滞有关。

English Abstract

参考文献 (21)

目录

    /

    返回文章
    返回